Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

DOJ Sues UnitedHealth Group Inc (NYSE:UNH) For Inflated Payments On Medicare Advantage

- May 3, 2017
Medtronic Plc

CRT Devices From Medtronic plc. Ordinary Shares (NYSE:MDT) Found To Be Cost-Effective

New Challenges In Alere Inc (NYSE:ALR) – Abbott Laboratories (NYSE:ABT)’s Expected Merger

What Should Aduro BioTech Inc (NASDAQ:ADRO) Investors Do Now?

Teva Pharmaceutical Industries Ltd

Here’s What’s Moving Teva Pharmaceutical Industries And Madrigal Pharmaceuticals

orphan drug

Orphan Drugs On a Roll, A Look Into the 2016 Orphan...

David Rich - March 21, 2016 0
Abbott Laboratories

Abbott Laboratories (NYSE:ABT) Releases Software Updates To Protect St Jude Pacemakers...

Andy Parker - August 30, 2017 0

Phase I Trial For Galapagos NV (ADR) (NASDAQ:GLPG) GLPG3067 For Cystis...

- March 23, 2017 0

Here’s What to Look out for in the XBiotech Inc (NASDAQ:XBIT)...

Roger Hannington - May 25, 2016 0

Celgene Corporation (NASDAQ:CELG) Teams Up With Olympic Swimmer On Psoriasis Awareness

Andy Parker - August 23, 2016 0

Here’s What’s Moving CytRx Corporation (NASDAQ:CYTR) and Sunshine Heart Inc (NASDAQ:SSH)

- April 20, 2017 0

Monday Movers In Biotech: Cempra Inc (NASDAQ:CEMP) and IntelliPharmaCeutics Intl Inc...

- February 27, 2017 0
Amgen

Amgen, Inc. (NASDAQ:AMGN)’s Enbrel To Face Competition From Biogen Inc (NASDAQ:BIIB)’s...

Andy Parker - January 18, 2016 0
biotech report

Weekly Biotech Report II – Marinus Pharmaceuticals Inc. (NASDAQ:MRNS) To Release...

David Rich - May 17, 2016 0
biotechnology

Here’s What The Latest Data Means For Insmed Incorporated (NASDAQ:INSM)

- September 6, 2017 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 2, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

October 19, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

October 13, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019